NCT03793985View on ClinicalTrials.gov

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

October 23, 2018

Study Completion Date

November 13, 2018

Conditions
Hyperlipidemias
Interventions
DRUG

T

CKD-391 40/10mg

DRUG

R

D086 and D337 co-administration

Trial Locations (1)

Unknown

INHA University Hospital, Incheon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY